Sources | Names Used |
---|---|
CTRPv2 | vorinostat:navitoclax (4:1 mol/mol) |
PharmacoGx | vorinostat:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ARHGAP33 | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-14 |
mRNA | KIAA1147 | CTRPv2 | pan-cancer | AAC | 0.27 | 9e-14 |
mRNA | TMSB15A | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-13 |
mRNA | CTC-398G3.6 | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-12 |
mRNA | CBFA2T2 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-12 |
mRNA | TAGLN3 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-12 |
mRNA | YPEL1 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-12 |
mRNA | ELAVL3 | CTRPv2 | pan-cancer | AAC | 0.29 | 6e-12 |
mRNA | ZNF606 | CTRPv2 | pan-cancer | AAC | 0.25 | 9e-12 |
mRNA | KIAA0408 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-11 |